Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function
by
Dawei Fan 1,2,3,†, Yassar Alamri 4,5,6,†
, Karen Liu 1,2,3, Michael MacAskill 4, Paul Harris 7, Margaret Brimble 3,7, John Dalrymple-Alford 3,4,8, Tim Prickett 6, Oliver Menzies 9, Andrew Laurenson 5, Tim Anderson 2,3,4,5,6,10 and Jian Guan 1,2,3,*
Dawei Fan 1,2,3,†, Yassar Alamri 4,5,6,†, Karen Liu 1,2,3, Michael MacAskill 4, Paul Harris 7, Margaret Brimble 3,7, John Dalrymple-Alford 3,4,8, Tim Prickett 6, Oliver Menzies 9, Andrew Laurenson 5, Tim Anderson 2,3,4,5,6,10 and Jian Guan 1,2,3,*
1
Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1142, New Zealand
2
Centre for Brain Research, Faculty of Medicine and Health Science, University of Auckland, Auckland 1142, New Zealand
3
Brain Research New Zealand, A Centre of Research Excellence, New Zealand
4
New Zealand Brain Research Institute, Christchurch 8011, New Zealand
5
Canterbury District Health Board, Christchurch 8041, New Zealand
6
Department of Medicine, University of Otago, Dunedin 9016, New Zealand
7
Department of Medicinal Chemistry, School of Chemistry, University of Auckland, Auckland 1142, New Zealand
8
Department of Psychology, University of Canterbury, Christchurch 8041, New Zealand
9
Department of Geriatric Medicine, Auckland District Health Board, Auckland, 1142, New Zealand
10
Department of Neurology, Christchurch Public Hospital, Christchurch 8140, New Zealand
*
Author to whom correspondence should be addressed.
â€
Authors with similar contributions to the research project.
Nutrients 2018, 10(6), 714; https://doi.org/10.3390/nu10060714
Received: 3 May 2018 / Revised: 30 May 2018 / Accepted: 31 May 2018 / Published: 2 June 2018
Background: Insulin-like growth factor-1 (IGF-1) function is impaired in Parkinson disease. Cyclic glycine-proline (cGP), a metabolite of IGF-1, is neuroprotective through improving IGF-1 function. Parkinson disease patients score lower on Hospital-associated Anxiety and Depression Scale after supplementing blackcurrant anthocyanins (BCA), which may be associated with IGF-1 function. We evaluated the changes of cGP and IGF-1 before and after the supplementation. Methods: Plasma and cerebrospinal fluid (CSF) were collected from 11 male patients before and after 28 day supplementation of BCA. The concentrations of IGF-1, IGF binding protein (IGFBP)-3, and cGP were measured using ELISA and HPLC-MS assays. The presence of cGP in the BCA was evaluated. Results: cGP presented in the BCA. BCA supplementation increased the concentration of cGP (p < 0.01), but not IGF-1 and IGFBP-3 in the CSF. CSF concentration of cGP was correlated with plasma concentration of cGP (R = 0.68, p = 0.01) and cGP/IGF-1 molar ratio (R = 0.66, p = 0.01). The CSF/plasma ratio was high in cGP and low in IGF-1 and IGFBP-3. Conclusion: cGP is a natural nutrient to the BCA. The increased CSF cGP in Parkinson disease patients may result from the central uptake of plasma cGP. Given neurotrophic function, oral availability, and effective central uptake of cGP, the BCA has the potential to be developed to treat neurological conditions with IGF-1 deficiency.
View Full-Text
Keywords:
cyclic Glycine-Proline (cGP); bioavailability of insulin-like growth factor-1 (IGF-1); Parkinson disease; blackcurrant anthocyanins; autocrine regulation; cerebrospinal fluid; central uptake
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
- Supplementary File 1:
PDF-Document (PDF, 96 KB)
MDPI and ACS Style
Fan, D.; Alamri, Y.; Liu, K.; MacAskill, M.; Harris, P.; Brimble, M.; Dalrymple-Alford, J.; Prickett, T.; Menzies, O.; Laurenson, A.; Anderson, T.; Guan, J. Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function. Nutrients 2018, 10, 714.
Show more citation formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Search more from Scilit
